Dermatitis atópica

  • María Isabel Barona Cabal Universidad del Valle
  • Adriana Arrunátegui Ramírez Universidad del Valle
Palabras clave: Dermatitis atópica

Resumen

La dermatitis atópica (DA) es una erupción eczematosa, pruriginosa, recurrente, simétrica que se asocia frecuentemente con historia familiar o personal de asma, rinitis alérgica, o eczema.

En su etiopatogenia se han implicado: 1- Aspectos fisiológicos y farmacológicos. 2- Anormalidades del metabolismo del AMP cíclico. 3- Alteraciones inmunológicas. Se están haciendo intentos para correlacionar estos diferentes factores y construir un modelo para la DA.

El papel de los alimentos sigue siendo muy controvertido. Como resultado de las alteraciones metabólicas e inmunológicas se presentan complicaciones no sólo en piel sino también en otros sistemas.

El tratamiento debe ir encaminado a la prevención y alivio del prurito. Actualmente se realizan estudios con inhibidores de la fosfodiesterasa y las citocinas en un intento por tratar la causa básica del prurito.

Biografía del autor/a

María Isabel Barona Cabal, Universidad del Valle

Docente adjunto Facultad de Salud Sección Dermatología, Universidad del Valle, Cali, Colombia.

Adriana Arrunátegui Ramírez, Universidad del Valle

Docente adjunto Facultad de Salud Sección Dermatología, Universidad del Valle, Cali, Colombia.

Referencias bibliográficas

Hanifin JM. Atopic Dermatitis. J Am Dermatol 1987; 6:1-13.,

https://doi.org/10.1016/S0190-9622(82)70001-5

Coca AF, Wallzer FM, Thommes AA. Asthma anti Hay fever in theory and practice. Springfield, II., 1931, Charles C. Thomas, Publisher, P 38.

Coca AF, Cooke RA. On the classification of the phenomena of hypersensitiveness. J Immunol 1923; 8:163-187.

Roth HL. Atopic Dermatitis Revisited, Int J Demiatol 1987; 26:139-149.

https://doi.org/10.1111/j.1365-4362.1987.tb00880.x

Solomon L Atopic Dermatitis, In: Dermatology, Moschella SL, Pillsbury DM, Hurley 11J. VVB. Saunders Com 1985; 334-353.

Blaylock KW. Atopic Dermatitis, In: Dermatologic Immunology and Allergy, Julius Stone; CV Mosby Company 1985. St Louis 315 322.

Escobar CE. Atopia. En: Fundamentos de Medicina; Vélez H, Borrero L, Restrepo J. Dermatología. Fallabella R, Escobar CE, C.iraldo N, Cuarta edición. Corporación para Investigaciones Biológicas, Medellín Colombia Pág. 54 64; 1990.

Hill LW, Sulzberger MB. Evolution of atopic dermatitis. Arch Dermatol 1935; 35:451-63.

https://doi.org/10.1001/archderm.1935.01470030093010

Hanifin JM, Lobitz WC Jr. Newer concepts of atopic dermatits. Arch Dermatol 1977; 113:663-670.

https://doi.org/10.1001/archderm.1977.01640050123023

Hanifin JM. Immunologic aspects of atopic dermatitis In: Dermatologic Clinics 1990; 8:747-50.

https://doi.org/10.1016/S0733-8635(18)30461-3

Barker JN, McDonald DM Epidermal class II human lymphocyte antigen expression in atopic dermatitis: A comparison with experimental allergic contact dermatitis. J Am Acad Demiatol 1987; 16:1175-9.

https://doi.org/10.1016/S0190-9622(87)70153-4

Rajka G. Prurigo Besnier (Atopic dermatitis) with special reference to the role of allergic factors. Immune influencia of atopic hereditary factors. Acta Derm Venereol (Stockh) I960; 40:285-306.

Bystryn JC, Hyman C Skin blood How in atopic dermatitis. J Invest Dermatol 1969; 52:189.

https://doi.org/10.1038/jid.1969.29

Abrams G, Farber E. Peripheral vascular responses in atopic dermatitis. Arch Demiatol 1963; 88:554

https://doi.org/10.1001/archderm.1963.01590230062009

Johnson LA, Winkelman R K. Cutaneous vascular reactivity in atopic children. Arch Dermatol 1965; 92:621.

https://doi.org/10.1001/archderm.1965.01600180013002

Whittfield A. On the white reaction (white line) in dermatology. Br J Dermatol 1938; 50:71.

https://doi.org/10.1111/j.1365-2133.1938.tb10475.x

Lobitz VVC Jr, Campbell CJ. Physiologic studies in atopic dermatitis. Arch Dermatol 1953; 67:575.

https://doi.org/10.1001/archderm.1953.01540060037006

Illig L. Derma Wochnschr 127:753,1952, citado por Rajka G In Acta Demi Venereol I960; 40:285.

Michelsson G. Decreased cutaneous reactions to kalikrein in patients with atopic dermatitis and psoriaris, Acta Derm Venereol 1970; 50:37.

Juhlin L. The rate of iontophoretically introduced epinephrine and norepinephrine in patients with atopic demiatitis and nonnal skin. J Invest Dermatol 1961; 37:257.

https://doi.org/10.1038/jid.1961.117

Solomon LM Wentzel HE, Tusky E. The physiological disposition of C14 norepinephrine in patients with atopic dermatitis and other dermatoses. J Invest Dermatol 1964; 43:193.

https://doi.org/10.1038/jid.1964.142

Solomon LM, Nadler N. Radioautography of noradrenaline C 14 in atopic dermatitis. Can Med Assoc J 1967; 96:1147.

Williams RC, Griffiths RW, Emmons JIT Naturally ocurring human antiglobulins with especifity for lamda E. J Inv Dermatol 1972; 51:955 63.

https://doi.org/10.1172/JCI106890

Szentivanyi A The beta adrenergic theory of the atopic abnormally in branchial asthma. J Allergy 1968; 42:203.

https://doi.org/10.1016/S0021-8707(68)90117-2

Bourne Hr, Lichtenstein LM, Melmon KL. Modulation of inflamation and immunity by ciclic AMP. Science. 1974; 184:19 28.

https://doi.org/10.1126/science.184.4132.19

McMillan JC, Heskel NS, Hanifin JM. Ciclic AMP phosphodiesterase activity and histamine release in cord blood leukocyte preparations. Acta Derm Venereol (Suppl) (Stockh) 1985; 114:24-32.

Holden CA, Chung ting Y: Response of elevated phosphodiesterase activity to topical steroids in atopic dermatitis. J Am Acad Dermatol 1989; 2L69-74.

Jones HE, Reinhardt JH, Rinaldi MG. A clinical mycological and immunological survey for dermatophytosis. Arch Dermatol 1973 108:61.

https://doi.org/10.1001/archderm.1973.01620220033008

Jones HE, Lewis C, McMarlin SL, Allergic contact sensivity in atopic dermatitis. Arch Dermatol 1973; 107:217 22.

https://doi.org/10.1001/archderm.1973.01620170029009

Palacios J, Fuller EW, Blaylock WK. Immunological capabilities of patients with atopic dermatitis. J Invest Dermatol 1966 47:490 494.

https://doi.org/10.1038/jid.1966.172

Lobitz WC, Honey JF, Winkler MW. Suppressed cell- mediated immunity in two adults with atopic dermatitis. Br J Dermatol 1972; 86:317-328.

https://doi.org/10.1111/j.1365-2133.1972.tb05045.x

Rachelefsky GS, Opel ZG, Michi ME, et al. Defective T cell function in atopic dermatitis. J Allergy Clin Immunol 1976; 56:569-576.

https://doi.org/10.1016/0091-6749(76)90008-7

Byron NA, Straughton RCD, Campbell MA, Timnn DM, et al. Thymosin inducible "null" cell in atopic eczema. Br. J Dermatol 1979; 100:499-510.

https://doi.org/10.1111/j.1365-2133.1979.tb05575.x

Leung DYM, Rhodes AR, Geha RS, Enumeration of T cell subsets in atopic demiatitis using monoclonal antibodies. J Allergy Clin lnmmunol 1981; 67;450.

https://doi.org/10.1016/0091-6749(81)90098-1

Romagnani S, Maggi E, Delprete G, et al. Regulatory mechanisms of in vitro human IgE synthesis. Allergy 44 (Suppl 9):9; 1989.

https://doi.org/10.1111/j.1398-9995.1989.tb04309.x

Plauts M, Pierce JH, Watson C, et al. Mast cells lines produce lymphokines in response to cross-linkage of FcER1 or to Calcium ionophores. Nature 1989; 339:64.

https://doi.org/10.1038/339064a0

Brown MA, Pierce JH, Watson CJ et al. B cell Stimulatory factor 1/interleukin 4mRNA is expressed by normal and transformed mast cells. Cell 1987; 50 809.

https://doi.org/10.1016/0092-8674(87)90339-4

Meneghini CL, Bonifazi E. The role of foods in atopic dermatitis. Int J Dermatol 1985; 24:158 60.

https://doi.org/10.1111/j.1365-4362.1985.tb05409.x

Rajka G. Atopic Demiatitis correlation of enviromental factor with frecuency. Int J Dermatol 1986; 25:301- 304.

https://doi.org/10.1111/j.1365-4362.1986.tb02249.x

Bahna S Furukawa CT. Food Allergy: Diagnosis and treatment. Ann Allergy 1983; 51:574 580.

Bruynzeel-koomen CAF, VanWichen DF, Spry CJF, et al. Active participation of eosinophils in pach test reactions to inhalant allergen in patients with atopic dermatitis. Br J Demiatol 1988; 118:229 238.

https://doi.org/10.1111/j.1365-2133.1988.tb01779.x

Bjomeboe A, Soyland E, Bjomeboe GE, et al. Effect of dietary supplemen tations with eicosapentaenoic acid in the treatment of atopic demiatitis. Br J Demiatol 1987; 117:463- 69.

https://doi.org/10.1111/j.1365-2133.1987.tb04926.x

Gondo A, Saeki N, Tokuda Y. lgG4 antibodies in patients with atopic dermatitis. Br J Dermatol 1987; 117:301-310.

https://doi.org/10.1111/j.1365-2133.1987.tb04136.x

Noms FG, Rivers JK. Screening for cataracts in patients with severe atopic eczema. Clin Exp Demiatol 1987; 12:21-22.

https://doi.org/10.1111/j.1365-2230.1987.tb01847.x

Hauser C. The role of Staphylococcus aureus in atopic dermatitis, Int J Demiatol 1986; 25:573-75.

https://doi.org/10.1111/j.1365-4362.1986.tb04698.x

Cole WC, Roth H L, Lewis BC. Group psychotherapy as an aid in the medical treatment of eczema. J Am Acad Demiatol 1988; 18:286-91.

https://doi.org/10.1016/S0190-9622(88)70041-9

Abramson JS, Dahl MV, Walsh G, et al. Antistaphylococcal IgE in patients with atopic dermatitis. J Am Acad Dermatol 1982 7:105-110.

https://doi.org/10.1016/S0190-9622(82)80017-0

Rosen K, Mabacken H, Swanbeck G. Chronic Eczematous Dermatitis of the hands: A comparison of PUVA and UVB treatment. Acta Demiat Venerol 1987; 67:48-54.

Hanifin JM. Atopic Demiatitis: New Therapeutic considerations. J Am Demiatol 1991; 24:1097 101.

https://doi.org/10.1016/0190-9622(91)70165-X

Cómo citar
1.
Barona Cabal MI, Arrunátegui Ramírez A. Dermatitis atópica. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de noviembre de 1991 [citado 27 de septiembre de 2022];1(2):65-0. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1447

Descargas

La descarga de datos todavía no está disponible.
Publicado
1991-11-01
Sección
Monografía